A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...
“ The Carterra Vega platform is a technological leap forward—a true step change. Faster hit discovery with 48 parallel ...
Aly, a clinical epidemiologist and chief of research and development at VA St Louis Health Care System in the US, who led the ...
More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.
The Food & Drug Administration is easing some of its guidelines on what can be labeled as having "no artificial colors." In a statement, the FDA states that "Companies will now have flexibility to ...
Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...
At a Glance The FDA reversed its 2022 NMN ban in September 2025, allowing the $500 million ingredient back on the market ...
Moving a potential therapy from the laboratory to the pharmacy has always been a slow, incremental journey. “Drug development is a multi-stage process,” says Nichola McCann, associate principal ...
Data support potential of isaralgagene civaparvovec as a one-time, well tolerated and durable Fabry disease gene therapy to provide meaningful, ...
Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates February 2, 2026 7:01 PM ESTCompany ParticipantsGary ...
Drug development is an unforgiving business. Discovering a novel molecule is difficult enough, but then it can take years of preclinical studies and molecular tweaking to mitigate a drug’s toxicity, ...
Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia February 3, 2026 10:30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results